Conceptio › Archive › HAL (France)
HAL (France)open access

COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network

Charlotte Laniece Delaunay et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
covideurope
SARS-CoV-2, 2, Europe, COVID-19, Vaccine effectiveness, 0, 1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 408713
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.